Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-2024-08-06· OpenAIAi2 WildChat-4.8M (AI2)

Hey, this is an English text. I want you to translate it into the Tunisian dialect.…

  1. User

    Hey, this is an English text. I want you to translate it into the Tunisian dialect. Please follow these steps:

    1. Translate step by step and highlight differences between Tunisian dialect and Modern Standard Arabic.
    2. Highlight sections you are confident translating into the Tunisian dialect. Translate this text into the Tunisian dialect, focusing on capturing the essence of the language nuances:

    Mylan and Fujifilm Kyowa Kirin Biologics said on Thursday they had won a European Commission green light to market their version of the injectable medicine, known as Hulio. They intend to launch it in Europe on or after Oct. 16, when AbbVie’s primary European patent on Humira expires. The large number of Humira copies reflects intense rivalry for a slice of a huge market as demand for so-called biosimilars takes off in Europe, where adoption of the cut-price products has been much faster than in the United States. SPONSORED Europe accounted for around $4.4 billion of Humira’s global sales in the 12 months to June 30, 2018, according healthcare data consultancy IQVIA. Amgen, Novartis’s generics wing Sandoz, South Korea’s Samsung Bioepis and Germany’s Boehringer Ingelheim have already won approval for four other biosimilars to Humira. Humira is used to treat a range of conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis and psoriasis. Its commercial success and popularity among patients means it has become a major cost for health systems across Europe, and health administrators say they will waste no time in exploiting the arrival of cheaper biosimilars to drive down bills. Because injectable biologic drugs such as Humira are made in living cells, they cannot be exact replicas of the original medicine, so regulators have come up with the notion of biosimilars – drugs that are similar enough to do the job. The conventional wisdom has been that biosimilar uptake would be slow and price discounts modest, since these products are expensive to develop and doctors may be wary about using a medicine that isn’t identical to the original. But Europe’s recent experience with the first wave of biosimilar antibody drugs – the biggest section of the biologic market – has upended expectations, suggesting AbbVie will face fierce competition. Still, analysts don’t expect global Humira sales to fall off a cliff just yet, since there are delays in the arrival of biosimilars in the all-important U.S. market. While expiry of the Humira patent opens the door to biosimilars in Europe, such copies are not expected to launch in the United States until 2023.

  2. Assistant

    Sure! Let's translate this text into the Tunisian dialect step by step.

    1. Original Sentence: "Mylan and Fujifilm Kyowa Kirin Biologics said on Thursday they had won a European Commission green light to market their version of the injectable medicine, known as Hulio."

      Tunisian Dialect: "شركة Mylan وفوجيفيلم كيوا كيرين بيولوجيكس قالوا نهار الخميس إللي ربحوا الضوء الأخضر من المفوضية الأوروبية باش يروجوا النسخة متاع الدواء القابل للحقن، المكناة بهوليو."

      Differences:

      • "قالوا نهار الخميس" is a more casual way of saying "said on Thursday" compared to the formal "قالوا يوم الخميس" in MSA.
      • "إللي" is a common Tunisian way to say "that", whereas in MSA it would be "أن".
      • "الضوء الأخضر" is a common expression borrowed from French used in Tunisian, meaning "approval" or "green light."
    2. Original Sentence: "They intend to launch it in Europe on or after Oct. 16, when AbbVie’s primary European patent on Humira expires."

      Tunisian Dialect: "ناويين يهبطوه في أوروبا نهار أو بعد 16 أكتوبر، وقت اللي تنتهي البراءة الرئيسية الأوروبية متاع Humira."

      Confident Sections:

      • "ناويين يهبطوه" translates to "They intend to launch it," showing casual intent.
      • "تنتهي البراءة" means "the patent expires."
    3. Original Sentence: "The large number of Humira copies reflects intense rivalry for a slice of a huge market as demand for so-called biosimilars takes off in Europe, where adoption of the cut-price products has been much faster than in the United States."

      Tunisian Dialect: "النسخ الكثيرة من Humira تعكس المنافسة الكبيرة على جزء من السوق الضخم كيفاش الطلب على ما يسمّى بيوسيمليرز يزيد في أوروبا، وين تبني المنتجات الرخيصة كان أسرع برشا من الولايات المتحدة."

      Differences:

      • "كيفاش" instead of "كما" in MSA for "as."
      • "وين" is commonly used for "where" instead of "حيث".
    4. Original Sentence: "Europe accounted for around $4.4 billion of Humira’s global sales in the 12 months to June 30, 2018, according healthcare data consultancy IQVIA."

      Tunisian Dialect: "أوروبا مثّلت حوالي $4.4 مليار من مبيعات Humira العالمية في ال12 شهر حتى 30 جوان 2018، حسب ما قالت شركة الاستشارات الصحية IQVIA."

      Confident Sections:

      • "حوالي 4.4مليار"for"around4.4 مليار" for "around 4.4 billion."
      • "حتى 30 جوان" instead of "حتى 30 يونيو," reflecting how months are often pronounced in French-influenced style.
    5. Original Sentence: "Amgen, Novartis’s generics wing Sandoz, South Korea’s Samsung Bioepis and Germany’s Boehringer Ingelheim have already won approval for four other biosimilars to Humira."

      Tunisian Dialect: "Amgen، الجناح الجنيريكي لسندوز متاع نوفارتس، سامسونج بيويبس الكورية الجنوبية وبويرينجر انغليهايم الألمانية خذوا الموافقة لأربع بيوسيمليرز آخرين لـHumira."

      Differences:

      • "الجناح الجنيريكي" is an adapted phrase for "generics wing."
      • "خذوا الموافقة" instead of "حصلوا على الموافقة."
    6. Original Sentence: "Humira is used to treat a range of conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis and psoriasis."

      Tunisian Dialect: "Humira تُستَعمَل باش تعالج مجموعة حالات بما فيها التهاب المفاصل الروماتويدي، مرض كرون، التهاب القولون التقرحي والصدفية."

      Confident Sections:

      • "تُستَعمَل باش تعالج" is a typical phrasing for "is used to treat."
      • Disease names are often left in their original or slightly adjusted form.
    7. Original Sentence: "Its commercial success and popularity among patients means it has become a major cost for health systems across Europe, and health administrators say they will waste no time in exploiting the arrival of cheaper biosimilars to drive down bills."

      Tunisian Dialect: "النجاح التجاري متاعها والشعبية متاعها عند المرضى يعني إنها ولات تكلفة كبيرة على الانظمة الصحية في أوروبا، والمسؤولين الصحيين يقولوا إنهم مش باش يضيعوا الوقت في استغلال وصول البيوسيمليرز الأرخص باش ينقصوا من الفواتير."

      Confident Sections:

      • "النجاح التجاري" for "commercial success."
      • "مش باش يضيعوا الوقت" is idiomatic Tunisian for "will not waste time."
    8. Original Sentence: "Because injectable biologic drugs such as Humira are made in living cells, they cannot be exact replicas of the original medicine, so regulators have come up with the notion of biosimilars – drugs that are similar enough to do the job."

      Tunisian Dialect: "خاطر الأدوية البيولوجية القابلة للحقن كيما Humira تصنع في خلايا حية، ما ينجمش يكونوا نسخ طبق الأصل للدواء الأصلي، لهيك الهيئات التنظيمية جابوا فكرة البيوسيمليرز – أدوية تشبه كفاية باش تقوم باللازم."

      Confident Sections:

      • "ما ينجمش يكونوا نسخ طبق الأصل" emphasizes the impossibility of identical copies.
      • "باش تقوم باللازم" for "to do the job."
    9. Original Sentence: "The conventional wisdom has been that biosimilar uptake would be slow and price discounts modest, since these products are expensive to develop and doctors may be wary about using a medicine that isn’t identical to the original."

      Tunisian Dialect: "الحكمة التقليدية كانت تقول إنو الاعتماد على البيوسيمليرز بش يكون بطيء والتخفيضات في الأسعار بش تكون محدودة، خاطرة تطوير هالمنتجات يكلف برشا والدكاترة يمكن يخافوا يستعملوا دواء مش هو نفسه الأصل."

      Differences:

      • "الحكمة التقليدية" for "the conventional wisdom."
      • "يخافوا يستعملوا" instead of the formal "قد يترددون في استخدام."
    10. Original Sentence: "But Europe’s recent experience with the first wave of biosimilar antibody drugs – the biggest section of the biologic market – has upended expectations, suggesting AbbVie will face fierce competition."

      Tunisian Dialect: "لكن التجربة الأخيرة متاع أوروبا مع الموجة الأولى من أدوية الأجسام المضادة البيوسيمليرز – أكبر قسم في سوق الأدوية البيولوجية – قلبت التوقعات، ما يشير إنو AbbVie بتواجه منافسة شديدة."

      Confident Sections:

      • "التجربة الأخيرة متاع أوروبا" adapts the meaning to "Europe's recent experience."
      • "قلبت التوقعات" directly translates to "upended expectations."
    11. Original Sentence: "Still, analysts don’t expect global Humira sales to fall off a cliff just yet, since there are delays in the arrival of biosimilars in the all-important U.S. market."

      Tunisian Dialect: "مع ذلك، المحللين ما يتوقعوش إنو مبيعات Humira العالمية بتطيح قريب، خاطر فما تأخيرات في وصول البيوسيمليرز للسوق اللي أهم أمريكا."

      Differences:

      • "ما يتوقعوش" is a Tunisian version of "do not expect."
      • "خاطر فما تأخيرات" means "since there are delays."
    12. Original Sentence: "While expiry of the Humira patent opens the door to biosimilars in Europe, such copies are not expected to launch in the United States until 2023."

      Tunisian Dialect: "ينتهي وقت البراءة متاع Humira يفتح الباب للبيوسيمليرز في أوروبا، لكن هالنسخ ما يتوقعش إنهم ينزلوا في الولايات المتحدة قبل 2023."

      Confident Sections:

      • "يفتح الباب" ("opens the door") is an idiomatic phrase in both languages.
      • "قبل 2023" ("until 2023") signifies the timeline similar to MSA.